# Safety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese Patients

> **NCT06947707** · — · RECRUITING · sponsor: **Xuanwu Hospital, Beijing** · enrollment: 1486 (estimated)

## Conditions studied

- Cerebral Venous Thrombosis
- Anticoagulants and Thrombotic Disorders
- Anticoagulation Treatment
- Anticoagulant Therapy
- Anticoagulant Drugs
- NOACs
- Anticoagulant Prophylaxis/Therapy
- Anticoagulation With NOAC
- Anticoagulation With Direct Oral Anticoagulants

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06947707
- **Lead sponsor:** Xuanwu Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-10
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 1486 (ESTIMATED)
- **Last updated:** 2025-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06947707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06947707, "Safety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06947707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*